Internal Investigations and Regulatory Enforcement

• Conducted a good number of investigations relating to FCPA on behalf of several multinational pharmaceutical and medical device companies with a focus on East Asia, particularly China, Japan, and Southeast Asia.*
• Conducted anti-corruption risk assessment and due diligence for several top private equity firms regarding proposed investments in China, Europe, South East Asia, and South America.*
• Represented a number clients in defending enforcement actions initiated by U.S. SEC with respect to potential violation of FCPA and securities laws.*

International Arbitration and Dispute Resolution

• Represented a Chinese shareholder in a shareholder agreement dispute against the U.S. shareholder before Hong Kong International Arbitration Centre. The dispute was governed by the Chinese laws, and involved a good number of factual witnesses and expert witnesses. *
• Represented a U.S. based pharmaceutical company in a dispute resulting from a share transfer agreement against the former shareholder of the target company before Hong Kong International Arbitration Centre. The dispute was governed by U.S. laws and Chinese laws, and involved legal and tax issues. The case was settled after a few rounds of hearings for the original claim and the counter claim.*
• Represented a U.S. based pharmaceutical company in a series of disputes resulting from a series of distributorship agreements against its distributor before Hong Kong International Arbitration Centre and China International Economic and Trade Arbitration Commission, and obtained favorable awards for a majority of the cases.*
• Represented a U.S. based adhesive materials manufacturer and its Chinese subsidiaries in complex commercial litigation in a number of Chinese High Courts relating to claims concerning trade secret infringement, unfair competition, trade mark and patent infringement.*
• Represented a Hong Kong based luxury brands distributor and its Chinese channel partners in complex commercial litigation in a Chinese High Court and Hong Kong High Court relating to claims concerning distributorship agreement, trade mark infringement, and unfair competition. *
• Represented an Italian manufacturer and its Chinese subsidiary in a commercial dispute against one of their major suppliers before China International Economic and Trade Arbitration Commission. It involved complicated legal issues under Chinese laws, as well as damages calculation.*
• Represented a shareholder in a share purchase dispute against prior shareholders before International Court of Arbitration.*
• Represented a private equity shareholder in a shareholder agreement dispute against a U.K. based prior shareholder before International Chamber of Commerce.*
• Advised a client on a number of international-law-related issues including expropriatory, fair and equitable treatment, full protection and security, and public order that would potentially be brought to International Centre for Settlement of Investment Disputes.*
• Represented a limited liability company’s CEO and majority unit holder in complex commercial litigation in the Delaware Court of Chancery relating to claims concerning contractual interpretation, fiduciary duties, and reformation of liability company agreement.*

*Matters handled in prior firms